Charles River Labs CFO Resigns, Interim Appointed

By Bobby Samwell • Tuesday, September 16 12:13 • Permanent Link

Charles River Laboratories International, Inc. (NYSE: CRL) has announced the resignation of Flavia H. Pease, the corporate executive vice president and chief financial officer (CFO), effective September 29, 2025. Following this development, Michael G. Knell, the corporate senior vice president and chief accounting officer, has been appointed as the interim CFO until a successor is named. The company has initiated a comprehensive search to identify its next CFO.

The company is reaffirming its 2025 financial guidance for revenue and non-GAAP earnings per share that was previously provided on August 6, 2025, which is supported by its current outlook for the third-quarter performance.

Charles River Laboratories International, Inc. defines “organic revenue growth” as reported revenue growth adjusted for foreign currency translation, acquisitions, and divestitures. The company excludes these items from the non-GAAP financial measures because they are outside its normal operations.

The press release also states that there are limitations in using non-GAAP financial measures, as they are not presented in accordance with generally accepted accounting principles, and may be different than non-GAAP financial measures used by other companies. The company believes that the use of supplementary non-GAAP financial measures helps investors to gain a meaningful understanding of its core operating results and future prospects without the effect of often-one-time charges, and is consistent with how management measures and forecasts the company's performance, especially when comparing such results to prior periods or forecasts.

The press release did not include specific figures or metrics to illustrate how the company's financial performance has changed since the last period. However, it emphasized the company's commitment to providing a seamless transition in the CFO role and its focus on executing its strategy and continuing to unlock value in its business. The market has reacted to these announcements by moving the company's shares -0.42% to a price of $152.24. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.